Pharma & Bio-Tech9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe Tejash & Dev2 days ago01 mins Frustrated by a slump that’s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier clinical trials, intellectual property protections and “fiscal flexibility.” Post navigation Previous: 7 Best Biotech ETFs to Buy NowNext: Cracks in public health grew in 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Yes, add me to your mailing list